The store will not work correctly when cookies are disabled.
3,3,20,20-Tetramethyl-docosanedioic acid
ID: ALA64929
Chembl Id: CHEMBL64929
PubChem CID: 14614317
Max Phase: Preclinical
Molecular Formula: C26H50O4
Molecular Weight: 426.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 3,3,20,20-Tetramethyl-Docosanedioic Acid | CHEMBL64929|3,3,20,20-Tetramethyl-docosanedioic acid|BDBM50018565
Canonical SMILES: CC(C)(CCCCCCCCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)O
Standard InChI: InChI=1S/C26H50O4/c1-25(2,21-23(27)28)19-17-15-13-11-9-7-5-6-8-10-12-14-16-18-20-26(3,4)22-24(29)30/h5-22H2,1-4H3,(H,27,28)(H,29,30)
Standard InChI Key: KYNVVGPJSSNATJ-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 426.68 | Molecular Weight (Monoisotopic): 426.3709 | AlogP: 8.23 | #Rotatable Bonds: 21 |
Polar Surface Area: 74.60 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.74 | CX Basic pKa: ┄ | CX LogP: 8.78 | CX LogD: 4.11 |
Aromatic Rings: ┄ | Heavy Atoms: 30 | QED Weighted: 0.18 | Np Likeness Score: 0.28 |
References
1. Bar-Tana J, Ben-Shoshan S, Blum J, Migron Y, Hertz R, Pill J, Rose-Khan G, Witte EC.. (1989) Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids., 32 (9): [PMID:2788743] [10.1021/jm00129a010] |